[Skip to Navigation]
Comment & Response
January 2018

Bortezomib for Neuromyelitis Optica Spectrum Disorder: A New Therapeutic Option for the More Severe Forms?

Author Affiliations
  • 1Department of Neurology, Research Institute and Hospital of the National Cancer Center, Goyang-si, Korea
JAMA Neurol. 2018;75(1):128-129. doi:10.1001/jamaneurol.2017.3447
Add or change institution
×